Clinical evaluation of urapidil (Ebrantil®), an α1-adrenergic blocker, on micturition disturbance due to benign prostatic hyperplasia (BPH), with estimate criteria for efficacy of treatment in BPH

Akito Yamaguchi, Souichiro Akasaka, Hideyasu Iwamoto, Kazuya Omoto, Takatoshi Konishi, Kyoko Soejima, Mineo Takei, Yasuhiro Tada, Katsunori Tatsugami, Shigeru Michinaga

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Clinical evaluation of urapidil (Ebrantil®), an α1-adrenergic blocker, on micturition disturbance due to benign prostatic hyperplasia (BPH), with estimate criteria for efficacy of treatment in BPH'. Together they form a unique fingerprint.

Medicine & Life Sciences